The high expression of ZNF281 may predict poor tumour response and prognosis in rectal cancer patients receiving NART, encouraging us to explore further the status of the expression and clinical relevance of ZNF281 in rectal carcinoma. The gene discussed is ZNF281; the disease is rectal carcinoma.